athenahealth, Inc. (NASDAQ:ATHN) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a note issued to investors on Thursday.

Other research analysts have also recently issued research reports about the stock. Jefferies Group LLC restated a “sell” rating and set a $95.00 target price on shares of athenahealth in a report on Friday, March 24th. Piper Jaffray Companies restated an “overweight” rating and set a $160.00 target price on shares of athenahealth in a report on Tuesday, April 4th. Oppenheimer Holdings, Inc. restated an “outperform” rating and set a $142.00 target price on shares of athenahealth in a report on Wednesday, April 19th. Cantor Fitzgerald restated a “buy” rating and set a $118.00 target price (down previously from $135.00) on shares of athenahealth in a report on Thursday, April 27th. Finally, Barclays PLC set a $88.00 target price on shares of athenahealth and gave the stock an “underweight” rating in a report on Monday, May 1st. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and twelve have issued a buy rating to the company. athenahealth has a consensus rating of “Hold” and an average price target of $146.45.

athenahealth (NASDAQ ATHN) traded up 8.44% during midday trading on Thursday, reaching $155.93. 2,286,356 shares of the company’s stock were exchanged. The stock has a market cap of $6.23 billion, a P/E ratio of 197.88 and a beta of 1.79. athenahealth has a 1-year low of $90.11 and a 1-year high of $158.66. The firm’s 50-day moving average is $141.51 and its 200 day moving average is $122.62.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.39 by $0.12. The company had revenue of $301.10 million during the quarter, compared to analysts’ expectations of $298.68 million. athenahealth had a net margin of 2.80% and a return on equity of 7.11%. The business’s quarterly revenue was up 15.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.34 earnings per share. Equities analysts anticipate that athenahealth will post $1.86 earnings per share for the current fiscal year.

WARNING: This piece of content was originally published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international copyright laws. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/07/23/athenahealth-inc-athn-raised-to-b-at-thestreet.html.

In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $140.52, for a total transaction of $562,080.00. Following the sale, the chief executive officer now directly owns 319,807 shares in the company, valued at $44,939,279.64. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Jonathan D. Porter sold 300 shares of the stock in a transaction dated Monday, May 15th. The stock was sold at an average price of $109.48, for a total transaction of $32,844.00. The disclosure for this sale can be found here. Insiders have sold 26,105 shares of company stock worth $3,394,859 over the last quarter. Corporate insiders own 3.20% of the company’s stock.

A number of large investors have recently made changes to their positions in ATHN. Reynolds Capital Management purchased a new stake in shares of athenahealth during the fourth quarter worth about $338,000. Tygh Capital Management Inc. increased its stake in athenahealth by 105.7% in the fourth quarter. Tygh Capital Management Inc. now owns 24,200 shares of the health services provider’s stock worth $3,895,000 after buying an additional 12,435 shares during the last quarter. Janus Capital Management increased its stake in athenahealth by 0.4% in the third quarter. Janus Capital Management now owns 3,528,584 shares of the health services provider’s stock worth $470,541,000 after buying an additional 14,767 shares during the last quarter. Simplex Trading increased its stake in athenahealth by 261.3% in the fourth quarter. Simplex Trading now owns 6,500 shares of the health services provider’s stock worth $1,046,000 after buying an additional 4,701 shares during the last quarter. Finally, Huntington National Bank increased its stake in athenahealth by 0.3% in the fourth quarter. Huntington National Bank now owns 47,820 shares of the health services provider’s stock worth $7,697,000 after buying an additional 162 shares during the last quarter.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.